e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Asthma management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of leikotriene modifiers promotes to decrease bronchial hyperreactivity in bronchial asthma patients
L. Iashyna, Y. Feshchenko, M. Polianska, I. Zvol, S. Ishchuk, L. Savelieva, A. Potochniak (Kiev, Ukraine)
Source:
Annual Congress 2012 - Asthma management
Session:
Asthma management
Session type:
Thematic Poster Session
Number:
3436
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Iashyna, Y. Feshchenko, M. Polianska, I. Zvol, S. Ishchuk, L. Savelieva, A. Potochniak (Kiev, Ukraine). Use of leikotriene modifiers promotes to decrease bronchial hyperreactivity in bronchial asthma patients. Eur Respir J 2012; 40: Suppl. 56, 3436
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Influence of endogenous corticosteroids on bronchial protective properties of β
2
-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Effect of bronchial neutrophilia on airway remodeling in asthma
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
Relationship between bronchial hyperresponsiveness and response to β
2
-agonists in steroid-naïve patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 503s
Year: 2002
Small airways involvement is associated with bronchial hyperresponsiveness in asthma
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012
Mechanisms of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Role of of symbicort in treatment of bronchial asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014
Evaluation of bronchial hyperreactivity and hypersensitivity in asthmatics and bronchitis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
The possible role of IL-5 and IFN-γ in the forming of cold airway hyperresponsiveness in patients with bronchial asthma
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008
Increased airway closure is a determinant of airway hyperresponsiveness
Source: Eur Respir J 2008; 32: 1563-1569
Year: 2008
Bronchial hyperreactivity in children with cough variant of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002
Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020
Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 4s
Year: 2001
How much do varying definitions of atopy and airway hyperresponsivenss affect asthma phenotype
Source: Eur Respir J 2001; 18: Suppl. 33, 287s
Year: 2001
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Source: Eur Respir J 2008; 32: 970-978
Year: 2008
Metabolic differences in bronchial epithelium from asthma patients and impact of bronchial thermoplasty
Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease
Year: 2020
The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept